Decreased susceptibility to lipid peroxidation of Goto-Kakizaki rats: Relationship to mitochondrial antioxidant capacity

Life Sciences

Volumn 65, Issue 10, 1999, Pages 1013-1025

  Ferreira, F M L ^a,d   Palmeira, C M ^a   Matos, M J ^b   Seic R ^c   Santos, M S ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Department of Biochemistry ^*  (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

tocopherol; Antioxidant enzymes; Goto Kakizaki rats; Lipid peroxidation; Mitochondria; Respiratory index; Type 2 diabetes mellitus

Indexed keywords

ALPHA TOCOPHEROL; FATTY ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; LIPID PEROXIDATION; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CELL RESPIRATION; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; LIPID PEROXIDATION; MALE; MITOCHONDRIA, LIVER; OXIDOREDUCTASES; OXYGEN CONSUMPTION; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; SUCCINATES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

ANIMALIA;

EID: 0033618489     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00332-X     Document Type: Article

References (45)

1. G. J. Biessels, A. C. Kappelle, B. Bravenboer, D. W. Erkelens and W. H. Gispen, Diabetologia 37 643-650 (1994).
2. L. C. Groop, J. Int. Med. 241 95-101 (1997).
3. P. R. Flatt, Y. H. A. Abdel-Wahab, A. C. Boyd, C. R. Barnett and F. P. M. O'Harte, Proc. Nutr. Soc. 56 243-262 (1997).
4. P. Serradas, M.-N. Gangnerau, M.-N. Giroix, C. Saulnier, L. A. H. Borg, and B. Portha, J. Clin. Invest. 101 899-904 (1998).
5. Y. Goto, M. Kakizaki and N. Masaki, Proc. Jap. Acad. 51 80-85 (1975).
6. Y. Goto and M. Kakizaki, Proc. Jap. Acad. 57 381-384 (1981).
7. Y. Goto, K. Susuki, T. Ono, M. Sasaki and T. Toyota, Adv Exp. Med. Biol. 246 29-31 (1988).
8. J. Duhault and E. Koenig-Berard , Thérapie 52 375-384 (1997).
9. L. E. Rikans, and K. R. Hornbrook, Biochem. Biophys. Acta 1362 116-127 (1997).
10. R. R. Ratan, T. H. Murphy and J. M. Baraban, J. Neurochem. 62 376-379 (1994).
11. P. A. Sandstrom and T. M. Buttke, Proc. Natl. Acad. Sci. USA 90 4708-4712 (1993).
12. H. Kaneto, J. Fujii, T. Myint, N. Miyazawa, K. N. Islam, Y. Kawasaki, K. Suzuki, M. Nakamura, H. Tatsumi, Y. Yamasaki and N. Taniguchi, Biochem. J. 320 855-863 (1996).
13. P. Gillery, J.-C. Monboissde and F.-X. Marquat, Med. Hypotheses 29 47-50 (1989).
14. K. D. Gerbitz, K Gempel and D. Brdiczka, Diabetes 45 113-126 (1996)
15. B. S. Kristal, S. J. Koopmans, C. T. Jackson, Y. Ikeno, B. J. Park and B. P. Yu, Free Rad. Biol. Med. 22 813-822 (1997).
16. B. S. Kristal, C. T. Jackson, H-Y. Chung, M. Matsuda, H. D. Nguyen and B. P. Yu, Free Rad. Biol. Med. 22 823-833 (1997).
17. P. Gazotti, K. Malmstron and M. Crompton, Membrane Biochemistry. A Laboratory Manual on Transport and Bioenergetics (eds E. Carafoli and G. Semenza), pp. 62-69, Springer-Verlag, New York (1979).
18. F. M. L. Ferreira, Madeira, V. M. C., and Moreno, A. J., Biochem. Pharmacol. 53 299-308 (1997).
19. M. M. Bradford, Anal. Biochem. 72 248-254 (1976).
20. J. J. Sedmak and S. E. Grossberg, Anal. Biochem. 79 544-552 (1977).
21. L. Ernster and K. Nederbrand, Meth. Enzymol. 10 574-580 (1967).
22. Y. C. M. De Hingh, J. Meyer, J. C. Fischer, R. Bergwer, J. A. M. Smeitink and J. A. F. Op Den Kamp, Biochem. 34 12755-12760 (1995).
23. E. D. Willis, Biochem. J. 113 315-324 (1969).
24. E. G. Bligh and W. J. Dyer, Can. J. Biochem. Physiol. 37 911-917 (1959).
25. V. M. C. Madeira and M. C. Antunes-Madeira CiêNcia BiolóGica (Portugal) 2 265-291 (1976).
26. A. P. D. Leenheer, V. O. R. C. D. Bevere and A. E. Claeys, Clin. Chem. 25 425-428 (1979).
27. G. W. Burton, A. Weeb and K. V. Ingold, Lipids, 20 29-39 (1985).
28. G. T. Vatassery, W. E. Smith, H. T. Quach and J. C. K. Lai, Neurochem. Int. 26 527-535 (1995).
29. P. J. Hissin and R. Hilf, Anal. Biochem. 74 214-226 (1976).
30. L. Flohé and W. A. Günzler, Meth. Enzymol. 105 141-121 (1984).
31. I. Calberg and B. Mannervik, Meth. Enzymol. 113 484-490 (1985).
32. L. Flohé and F. Õtting, Meth. Enzymol. 105 93-104 (1984).
33. B. Chance and G. R. Williams, Adv. Enzymol. 17 65-134 (1956).
34. M. F. Mccarty, Med. Hypotheses 49 143-152 (1997).
35. P. Z. Zimmet, Diabetes Care 18 1050-1064 (1995).
36. J. V. Hunt, R. T. Dean and S. P. Wolff, Biochem. J. 256 205-212 (1988).
37. K. A. Sukalski, K. A. Pinto and J. L. Berntson, Free Rad. Biol. Med. 14 57-65 (1993).
38. S. M. Thomas, J. M. Gebiki and R. T. Dean, Biochem. Biophys. Acta 1002 189-197 (1989).
39. S. Kaiser, P. Di Mascio, M. E. Murphy and H. Sies, Arch. Biochem. Biophys. 277 101-108 (1990).
40. G. T. Vatassery, W. E. Smith, and H. T. Quach, Neurochem. Int. 24 29-35 (1994).
41. A. Boveris and B. Chance , Biochem. J. 134 707-716 (1973).
42. D. J. Reed, Biochem. Pharmacol. 35 7-13 (1986).
43. G. Bellomo, F. Mirabelli, D. Dimonte, P. Richelmi, H. Thor, C. Orrenius and S. Orrenius, Biochem. Pharmacol. 36 1313-1320 (1987).
44. C. M. Palmeira, A. J. Moreno and V. M. C. Madeira, Toxicol. Lett. 81 115-123 (1995).
45. A. Meister, Science 220 471-477 (1983).